Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Assets (2010 - 2026)

Acadia Pharmaceuticals (ACAD) posted Assets of $1.7 billion for Q2 2026, up 8.58% on a QoQ basis from $1.6 billion in Q1 2026, and up 42.21% year-over-year from $1.2 billion in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) Assets (2010 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported Assets for 17 years, with the latest figure at $1.7 billion in Q2 2026.

  • On a quarterly basis, Assets rose 42.21% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 42.21% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 31.69% from the prior year.
  • Assets was $1.7 billion for Q2 2026 at Acadia Pharmaceuticals, up from $1.6 billion in the prior quarter.
  • The five-year high for Assets was $1.7 billion in Q2 2026, with the low at $587.8 million in Q4 2022.
  • Average Assets over 5 years is $980.1 million, with a median of $884.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Assets fell 17.34% in 2022, then surged 58.59% in 2024.
  • Over 5 years, Assets stood at $587.8 million in 2022, then increased by 27.41% to $749.0 million in 2023, then soared by 58.59% to $1.2 billion in 2024, then surged by 31.69% to $1.6 billion in 2025, then advanced by 11.42% to $1.7 billion in 2026.
  • The last three Assets figures came in at $1.7 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 201.06 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 135.12 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 115.83 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 49.36 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 27.42 Bn
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 1.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Bn
Mar 31, 2026 1.61 Bn
Dec 31, 2025 1.56 Bn
Sep 30, 2025 1.33 Bn
Jun 30, 2025 1.23 Bn
Mar 31, 2025 1.13 Bn
Dec 31, 2024 1.19 Bn
Sep 30, 2024 976.87 Mn
Jun 30, 2024 914.10 Mn
Mar 31, 2024 855.10 Mn
Dec 31, 2023 748.96 Mn
Sep 30, 2023 632.54 Mn
Jun 30, 2023 642.77 Mn
Mar 31, 2023 655.31 Mn
Dec 31, 2022 587.81 Mn
Sep 30, 2022 602.49 Mn
Jun 30, 2022 612.77 Mn
Mar 31, 2022 624.25 Mn
Dec 31, 2021 700.12 Mn
Sep 30, 2021 717.67 Mn
API Access

Acadia Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=ACAD&period=max&api_key=YOUR_API_KEY